Sympti
PrivateLast Round
Accelerator
Dec 17, 2020
Total Funding Raised
$150,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Sympti operates in Healthcare & Life Sciences and is based in Miami, Florida. Its latest recorded funding round was an Accelerator round in December 2020.
Sympti is a healthtech company that provides an artificial intelligence-driven medical service platform for patients to find and book urgent care, emergency rooms, and telehealth visits.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sympti Comparables
Compare Sympti with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clearstep | 86% | |
| DexCare | 78% | |
| Infermedica | 78% |
For institutional investors. Book with your work email.
Sympti Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Dec 17, 2020 | ||||
| Accelerator | Jun 5, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sympti Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Quake Capital | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 41% MoM.
- Jul 29, 2026
Monthly visitors grew 73% MoM.
For institutional investors. Book with your work email.
Sympti Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sympti's valuation, stock price, and market status.
Is Sympti a public or private company?
Sympti is a private company.
What is the current stock price of Sympti?
Sympti is a private company, so its shares have no public market price. Caplight tracks Sympti's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sympti worth (valuation)?
Valuation information for Sympti is not publicly available.
Can I buy Sympti stock?
Sympti shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sympti's last funding round?
Sympti's most recent funding round was Accelerator on December 17, 2020.
Who are the main investors in Sympti?
Key investors in Sympti include Quake Capital.
Will Sympti IPO soon?
No public IPO plans have been announced for Sympti.
How can I track Sympti secondary market activity?
Caplight tracks bids, offers, and trades in Sympti's shares on secondary markets.